Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDMD Baird Medical Investment	$2.58 -5.8%	$3.64	$1.05 ▼ $12.50	$18.04M	-1	260,801 shs	1.07 million shs
IINN Inspira Technologies OXY B.H.N.	$1.26 -5.6%	$1.12	$0.40 ▼ $1.65	$16.79M	2.3	332,504 shs	467,680 shs
NRXS NeurAxis	$2.37 -3.7%	$2.53	$1.33 ▼ $6.20	$17.10M	3.1	682,181 shs	69,626 shs
QNRX Quoin Pharmaceuticals	$7.37 +2.6%	$8.34	$5.01 ▼ $54.95	$4.22M	1.44	4,358 shs	1,833 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDMD Baird Medical Investment	+18.10%	+33.66%	-17.47%	-47.00%	+273,999,900.00%
IINN Inspira Technologies OXY B.H.N.	+3.91%	+9.02%	-5.00%	+151.42%	+31.68%
NRXS NeurAxis	-1.20%	-1.20%	-0.81%	+4.24%	-22.15%
QNRX Quoin Pharmaceuticals	+1.04%	+0.61%	-19.45%	-5.32%	-60.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	3.3136 of 5 stars	3.5	5.0	0.0	0.0	3.8	1.7	0.0
NRXS NeurAxis	2.8442 of 5 stars	3.5	3.0	0.0	0.0	2.4	3.3	0.0
QNRX Quoin Pharmaceuticals	1.1522 of 5 stars	0.0	4.0	0.0	0.0	2.9	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDMD Baird Medical Investment	0.00	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	3.00	Buy	$2.00	59.36% Upside
NRXS NeurAxis	3.00	Buy	$7.00	195.36% Upside
QNRX Quoin Pharmaceuticals	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest QNRX, NRXS, IINN, and BDMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	NRXS NeurAxis	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/16/2025	NRXS NeurAxis	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$7.00
6/2/2025	IINN Inspira Technologies OXY B.H.N.	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/2/2025	IINN Inspira Technologies OXY B.H.N.	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$2.00

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	$0.34 per share	N/A
NRXS NeurAxis	$2.93M	5.83	N/A	N/A	($0.27) per share	-8.78
QNRX Quoin Pharmaceuticals	N/A	N/A	N/A	N/A	$4.34 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDMD Baird Medical Investment	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	-$11.05M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
NRXS NeurAxis	-$14.63M	-$0.99	N/A	∞	N/A	-492.76%	N/A	-641.25%	N/A
QNRX Quoin Pharmaceuticals	-$8.96M	-$41.45	N/A	N/A	N/A	N/A	-210.50%	-99.41%	N/A

Latest QNRX, NRXS, IINN, and BDMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/7/2025	Q2 2025	QNRX Quoin Pharmaceuticals	-$6.83	-$6.28	+$0.55	-$6.28	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
NRXS NeurAxis	N/A	N/A	N/A	N/A	N/A
QNRX Quoin Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDMD Baird Medical Investment	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	0.09	2.02	1.89
NRXS NeurAxis	N/A	0.24	0.23
QNRX Quoin Pharmaceuticals	N/A	1.96	1.96

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDMD Baird Medical Investment	19.78%
IINN Inspira Technologies OXY B.H.N.	12.72%
NRXS NeurAxis	11.77%
QNRX Quoin Pharmaceuticals	8.63%

Insider Ownership

Company	Insider Ownership
BDMD Baird Medical Investment	78.90%
IINN Inspira Technologies OXY B.H.N.	29.40%
NRXS NeurAxis	26.40%
QNRX Quoin Pharmaceuticals	13.46%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDMD Baird Medical Investment	N/A	6.58 million	1.39 million	N/A
IINN Inspira Technologies OXY B.H.N.	20	12.62 million	8.91 million	Not Optionable
NRXS NeurAxis	19	7.22 million	6.09 million	Not Optionable
QNRX Quoin Pharmaceuticals	4	590,000	509,000	Not Optionable

QNRX, NRXS, IINN, and BDMD Headlines

Recent News About These Companies

Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton

August 12 at 8:30 AM | globenewswire.com

QNRX: Recent FDA & EMA Designations for QRX003 Potentially Could Accelerate Timeline

August 8, 2025 | finance.yahoo.com

Quoin (QNRX) Q2 Loss Beats Estimates

August 7, 2025 | fool.com

Quoin Pharmaceuticals stock rises after positive clinical updates

July 31, 2025 | investing.com

Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Product Portfolio Update

July 29, 2025 | finanznachrichten.de

Quoin Pharmaceuticals Provides Product Portfolio Update

July 29, 2025 | globenewswire.com

Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases - Morningstar

June 27, 2025 | morningstar.comM

Quoin Pharmaceuticals Releases New Episode of NETHERTON NOW Featuring Expert Insights on Netherton Syndrome - Nasdaq

June 27, 2025 | nasdaq.com

QNRX - Quoin Pharmaceuticals Ltd ADR Executives - Morningstar

June 26, 2025 | morningstar.comM

Quoin Pharmaceuticals Releases New NETHERTON NOW Video Featuring Professor Jemima Mellerio, International Expert in Genetic Skin Diseases

June 26, 2025 | finance.yahoo.com

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome - Yahoo Finance

June 25, 2025 | finance.yahoo.com

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Netherton Syndrome

June 24, 2025 | tmcnet.com

Quoin Pharmaceuticals, Ltd. (QNRX) - Yahoo Finance

June 24, 2025 | finance.yahoo.com

QNRX: With FDA Clearance to Initiate 2nd NS Whole Body Study for QRX003, Clinical Activities Expand Further

May 29, 2025 | finance.yahoo.com

Quoin Pharmaceuticals Announces FDA Clearance to Initiate Second Pivotal Whole Body QRX003 Netherton Syndrome Clinical Study

May 22, 2025 | manilatimes.netM

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome

May 20, 2025 | globenewswire.com

Quoin reports progress in pediatric skin disorder study

May 15, 2025 | investing.com

Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study

May 14, 2025 | globenewswire.com

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

May 14, 2025 | manilatimes.netM

A Peek at Quoin Pharmaceuticals's Future Earnings

May 12, 2025 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

QNRX, NRXS, IINN, and BDMD Company Descriptions

Baird Medical Investment NASDAQ:BDMD

$2.58 -0.16 (-5.84%)

As of 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.25 -0.08 (-5.64%)

Closing price 04:00 PM Eastern

Extended Trading

$1.25 0.00 (0.00%)

As of 07:29 PM Eastern

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

NeurAxis NASDAQ:NRXS

$2.37 -0.09 (-3.66%)

Closing price 04:00 PM Eastern

Extended Trading

$2.37 0.00 (-0.21%)

As of 07:44 PM Eastern

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Quoin Pharmaceuticals NASDAQ:QNRX

$7.36 +0.19 (+2.58%)

Closing price 03:58 PM Eastern

Extended Trading

$7.24 -0.13 (-1.70%)

As of 05:52 PM Eastern

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time